Latest news with #GMP
Daily News Egypt
2 hours ago
- Business
- Daily News Egypt
Egypt, US partner to launch global pharmaceutical manufacturing, export venture
Egypt has signed a major joint venture agreement with US-based Dawah Pharma to manufacture and export pharmaceutical products and nutritional supplements to global markets, with a strategic focus on North America and Europe. The deal marks a significant milestone in Egypt's push to expand its pharmaceutical exports and attract foreign investment to its health sector. Prime Minister Mostafa Madbouly witnessed the signing ceremony, which took place in the presence of Deputy Prime Minister for Human Development and Minister of Health and Population Khaled Abdel Ghaffar, Minister of Public Enterprise Sector Mohamed El-Shimy, Head of the Egyptian Drug Authority Ali El-Ghamrawy, and Hisham Setit, Head of the Unified Procurement Authority for Medical Supplies and Technology. The agreement was signed by Ashraf El-Khouly, Executive Managing Director of the Egyptian Holding Company for Pharmaceuticals—affiliated with the Ministry of Public Enterprise Sector—and Hossam Abdel Maksoud, Chairman of Dawah Pharma. Prime Minister Madbouly said the agreement reflects Egypt's broader strategy to enhance national industries, with the pharmaceutical sector identified as a key priority. He described the partnership as a strong vote of confidence in the quality and potential of Egyptian manufacturing, particularly in the medical field. Minister El-Shimy emphasized that the partnership follows major investments to modernize the holding company's infrastructure, upgrade production lines, and align operations with international Good Manufacturing Practices (GMP). He described the venture as a pivotal step in Egypt's plan to boost pharmaceutical exports, strengthen international collaboration, and increase foreign direct investment. Under the agreement, the new joint venture will manufacture and export a wide range of products including ampoules, nutritional supplements, sterile injections, ophthalmic preparations, and over-the-counter (OTC) medications. The first phase will focus on exporting six pre-approved dietary supplements to the US market—an unprecedented move for the Holding Company for Pharmaceuticals, after meeting all relevant international regulatory and quality benchmarks. The venture will leverage state-of-the-art manufacturing technologies for a diverse range of dosage forms including syrups, tablets, ampoules, pre-filled syringes, and transdermal patches. This is expected to accelerate global market entry for Egyptian-made products and support long-term growth for the company and its subsidiaries. El-Shimy affirmed that the new company will comply with the most stringent international regulations, particularly those set by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), to ensure the competitiveness of Egyptian products in North America, Europe, and emerging markets in Africa and Asia. As per the terms of the agreement, the Egyptian Holding Company for Pharmaceuticals will hold a 40% stake in the joint venture, while Dawah Pharma will own 60%. The partnership will also spearhead efforts to open new international markets for Egyptian pharmaceutical exports, solidifying Egypt's position as a regional hub for high-quality medical manufacturing.
Cision Canada
12 hours ago
- Business
- Cision Canada
Radyus Research and Eurofins CDMO Alphora Announce Strategic Partnership to Accelerate and Optimize Drug Development
ATLANTA and MISSISSAUGA, ON, May 28, 2025 /CNW/ -- Radyus Research, a U.S.-based drug development organization, and Eurofins CDMO Alphora, a Canadian contract development and manufacturing organization announced a new strategic partnership to help accelerate early-stage drug development for biotech companies worldwide. The partnership is built on a shared commitment to operational R&D excellence through long-term client collaborations. By integrating capabilities from preclinical development through clinical proof-of-concept, Radyus and Alphora aim to create a combined services offering to help clients reduce inefficiencies, eliminate handoffs, and improve the likelihood of drug program success. Radyus Research will contribute deep expertise in drug development strategy, efficacy and safety animal testing, regulatory planning, clinical trial operations and cross-functional program management. Eurofins CDMO Alphora will serve as the partnership's manufacturing engine, with a strong record in process development and GMP manufacturing for small molecule APIs, biologics and drug products. "We're excited to launch this partnership and unlock the value for our clients," said Marta New, CEO of Radyus Research. "It reflects our joint belief that long-term collaboration, rather than transactional engagement, is the key to efficient drug development. Together, we're surrounding our clients with a world-class, globally connected operating teams committed to delivering great results." "This alliance with Radyus enhances our ability to deliver cohesive strategies and executional excellence across the development continuum," Eurofins CDMO Alphora notes. "Together, we're building a high-trust model that reflects the collaborative, global nature of today's biopharmaceutical industry." Radyus Research and Eurofins CDMO Alphora are redefining early-stage drug development with a unified services solution: integrated, international, and focused on long-term client success. About Radyus Research Radyus Research is an integrated drug development organization specializing in preclinical and early clinical program strategy, R&D operations, regulatory submissions, and cross-functional program management. With global expertise and a milestone-driven approach, Radyus supports biotech companies from lead optimization through clinical validation of novel therapeutics and vaccines. About Eurofins CDMO Alphora Eurofins CDMO Alphora delivers fully integrated process development and GMP manufacturing solutions for small molecule APIs, drug products and biologics, supporting biopharmaceutical innovators from early development to commercialization. Enhanced by the scientific depth and geographic reach of the global Eurofins network of companies, Alphora provides clients with seamless access to advanced analytical services, bioanalysis, toxicology, clinical logistics, and biomarker discovery.
Business Upturn
13 hours ago
- Business
- Business Upturn
Vaisala Opens New Mumbai Office to Empower High-Tech Manufacturing in India
By PR Newswire Published on May 28, 2025, 18:35 IST MUMBAI, India , May 28, 2025 /PRNewswire/ — Vaisala, a global leader in measurement instruments and intelligence for climate action, proudly announces the establishment of Vaisala India and the grand opening of its new office in Mumbai . This strategic expansion reinforces Vaisala's commitment to supporting India's rapidly growing industrial sector, particularly in high-tech manufacturing fields such as life sciences, EV batteries, semiconductors, and electronic manufacturing services (EMS). "The Asia-Pacific (APAC) region has been a key market for Industrial Measurements, experiencing remarkable growth over the years. As several Asian economies mature, the time is right for us to expand into the world's 4th largest economy, paving the way for a dynamic new growth market." Mr. Berndt Köhring, Vice President of Vaisala Industrial Measurements APAC, said. The opening ceremony of Vaisala India on May 28 commenced with inspiring speeches. The speakers highlighted Vaisala's vision, strategic growth, and deep commitment to the Indian market. A traditional Lamp Lighting Ceremony followed, symbolizing enlightenment and prosperity, setting the stage for an exciting future. The formal commencement of operations was marked by a Ribbon Cutting Ceremony, officially inaugurating Vaisala India. Our esteemed guests, valued customers, trusted partners, and dedicated colleagues gathered to witness this momentous occasion. Dr. Eva Nilsson, Deputy Consul General of Finland in Mumbai, congratulated Vaisala for making the decision to expand operations to India . " Vaisala's decision to establish itself in Mumbai is a wonderful example of the commitment that Finland and Finnish companies have towards collaborating with India and deepening the ties between our economies. Finnish companies have world class technological solutions to offer to the Indian market, which supports India's commitment to Viksit Bharat 2047. " she stated. Mr. Kian Wei Yap, Director of Vaisala Industrial Measurements Other Asia Pacific, extended his gratitude, adding, "Thank you to our esteemed partners in India for your unwavering efforts and dedication, which have been instrumental in propelling our business to more than double its growth from 2018 to 2024. As we look ahead, together, we are confident that we can create even more value for our customers." Vaisala India is built on three key pillars that empower India's manufacturing landscape: Enhancing Precision & Compliance in Life Sciences – Vaisala's continuous monitoring systems ensure GMP compliance, data integrity, and precise environmental control for pharmaceutical manufacturing, biotech labs, and cleanrooms. Optimizing Battery Safety & Efficiency – Vaisala's dew point and humidity sensors optimize moisture-sensitive processes in the EV battery sector, enhancing performance, safety, and longevity. Ensuring Semiconductor & EMS Excellence – Vaisala provides advanced vacuum, humidity, and cleanroom monitoring solutions for semiconductor fabs and EMS facilities, ensuring superior yield optimization, static control, and process integrity. "We are proud to be part of India's transformative industrial journey, " Mr. Rajnikanth Umakanthan, General Manager of Vaisala Industrial Measurements India, concluded, "With the launch of Vaisala India, we are reinforcing our dedication to high-tech manufacturing. Alongside our partners, we are building a future where precision meets purpose, innovation meets sustainability, and India takes the lead in smart, responsible manufacturing." About Vaisala Vaisala is a global leader in measurement instruments and intelligence for climate action. We equip our customers with devices and data to improve resource efficiency, drive energy transition, and care for the safety and well-being of people and societies worldwide. With almost 90 years of innovation and expertise, we employ a team of close to 2,500 experts committed to taking every measure for the planet. Vaisala series A shares are listed on the Nasdaq Helsinki stock exchange. Photo – View original content: Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Business Upturn takes no editorial responsibility for the same. PR Newswire is a distributor of press releases headquartered in New York City.
Economic Times
14 hours ago
- Business
- Economic Times
Neptune Petrochemicals IPO sails through on Day 1. Check details
The initial public offering of Neptune Petrochemicals, which opened for subscription on Wednesday, was subscribed by 1.06 times at the end of the first day of the bidding process. ADVERTISEMENT The non-institutional investors (NIIs) had made 322 applications for a total of 17.53 lakh shares, while the qualified institutional buyers (QIBs) had applied for 27.76 lakh shares via 4 applications. The issue will remain open until May 30 and the company plans to raise Rs 73.20 crore through a fresh issue of 60 lakh shares. Ahead of the issue opening, there is no GMP in the unlisted market. Beeline Capital Advisors is managing the issue as the book-running lead manager, and MUFG Intime India (Link Intime) is the IPO is being offered in a price band of Rs 115 to Rs 122 per share. The shares will be listed on the NSE SME platform with a tentative listing date set for June investors can apply for a minimum of 1,000 shares, which amounts to Rs 1,22,000 at the upper price band. High-net-worth individuals (HNIs) can apply for a minimum of 2,000 shares with an investment of Rs 2,44,000. ADVERTISEMENT Incorporated in 2021, Neptune Petrochemicals is engaged in manufacturing and trading various grades of bitumen products, including polymer-modified and crumb-rubber-modified bitumen. The company's products are widely used in the construction and road-building sectors. It has three manufacturing units located in Ahmedabad (Gujarat), Panipat (Haryana), and Kamrup (Assam). It also exports products to neighbouring countries such as Nepal and Bhutan. ADVERTISEMENT For the nine months ended December 31, 2024, the company reported revenue of Rs 620 crore and a profit of Rs 19.47 crore. In the previous full year (FY24), Neptune had a profit of Rs 20.82 crore on revenue of Rs 675.97 crore. It has shown strong growth in a short period and maintains a healthy return on equity of 65 company plans to use the IPO proceeds to fund the purchase of office space, install new plant and machinery, meet working capital needs, and for general corporate purposes. ADVERTISEMENT Investors will be watching the subscription trends closely over the next few days, especially as the company is part of a fast-growing infrastructure segment. Its strong financials and niche product focus may attract interest, despite current cautious sentiment in the SME space. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)
Yahoo
15 hours ago
- General
- Yahoo
Police storm busy Greater Manchester road as driver arrested
A driver was arrested after police stormed a busy Rochdale road following a crash. Multiple Greater Manchester Police vehicles lined St Mary's Gate, near to the town centre, after 9.40am this morning (May 28). Images from the scene show a yellow Vauxhall Astra with a damaged front bumper and a missing front wheel on the passenger's side. READ MORE: The early wake up call which could have ended in chaos at Manchester Airport READ MORE: 'The three of us were standing together holding hands, in the blink of an eye everything changed' Part of the fencing by the side of St Mary's Gate, at the junction with Redcross Street, also appears to have been wrecked in the crash. It's understood that a lamppost was also struck in the collision, but no injuries were reported. GMP arrested a 20-year-old man at the scene following the crash. Join our Court and Crime WhatsApp group HERE He was seen being taken to a police custody van on St Mary's Gate after the collision. Police say he was arrested on suspicion of drugs possession and failure to provide a sample to officers. A GMP spokesperson said: "Officers were called at around 9.40am today to reports of a collision on Manchester Road, Rochdale. "A 20-year-old man was subsequently arrested on suspicion of drugs possession and failing to provide a sample." --- For the latest stories and breaking news visit Get the latest headlines, features and analysis that matter to you by signing up to our various Manchester Evening News newsletters here. You can also get all your favourite content from the Manchester Evening News on WhatsApp. Click here to stay up to date with the latest. Follow us on X @mennewsdesk for all the latest stories and updates on breaking incidents from across the region and beyond, as well as on our Facebook page here. If you prefer reading our stories on your phone, consider downloading the Manchester Evening News app here, and our newsdesk will make sure every time an essential story breaks, you'll be the first to hear about it.
